Kerri Robbins
Acute Care · Murfreesboro, TNNPI 1255602405
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $4,677 of the $5,676 with a category attached, or 82.4%. 22 manufacturers reported payments, led by Atricure, Inc. at 24.7% of the total. 2025 is the largest year on record at $2,146, more than ten times the $158 reported in 2021. Among acute care clinicians in TN with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 179 payments — averaging $31.71 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Atricure, Inc.$1K
- Amgen$782
- ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)$664
- Abbott$504
- Pfizer$328
- Johnson & Johnson$279
- plus $2K from 16 others
What the payments were for
- Travel & lodging$99918%
- Food & beverage$4,67782%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Atricure, Inc. | 8 | $1,401 |
| Amgen | 46 | $782 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 40 | $664 |
| Abbott | 4 | $504 |
| Pfizer | 20 | $328 |
| Johnson & Johnson | 13 | $279 |
| Bayer | 5 | $238 |
| Abiomed | 4 | $230 |
| AstraZeneca | 5 | $210 |
| E.r. Squibb & Sons, L.L.C. | 10 | $202 |
| Heartflow, Inc. | 4 | $182 |
| Novo Nordisk | 3 | $113 |
| Boehringer Ingelheim | 3 | $112 |
| Irhythm Technologies, Inc. | 1 | $105 |
| Actelion Pharmaceuticals US, Inc. | 1 | $99 |
| Novartis | 3 | $57 |
| Kiniksa Pharmaceuticals International, PLC | 2 | $41 |
| Sanofi-aventis U.S. LLC | 2 | $33 |
| Lexicon Pharmaceuticals, Inc. | 2 | $31 |
| Recor Medical Inc | 1 | $26 |
| AbbVie | 1 | $21 |
| Haemonetics Corporation | 1 | $18 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- EPI-SENSE GUIDED COAGULATION SYSTEM WITH VISITRAX$1,153
- SYNERGY ABLATION SYSTEM$1,153
- THORATEC HEARTMATE 3 LVAS IMPLANT KIT$313
- Epic$170
- FFRct$129
- Impella$124
- Kerendia$122
- ZIO XT Patch$105
- Zio monitor$105
- Repatha$105
How this compares
$5,676 in reported general payments places this provider in the 90th percentile of 738 acute care providers in Tennessee.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Atorvastatin Calcium | 12 | $124 |
Paid to pharmacies, not to this prescriber.
Other acute care in Murfreesboro
- Kelly JacksonMurfreesboro$27K
- Haley HoyNashville$368K
- Anne AlexandrovMemphis$110K
- Stephen MillerKnoxville$108K
- Shannon GraceNashville$57K
- Timothy BallardKnoxville$47K
- Kelsey MartinNashville$42K
- Barbara BrownNashville$36K
- Michelle GoochChattanooga$35K
- Elizabeth DavidsonNashville$33K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.